Abstract:Although a clear mechanism underlying the pathophysiology of schizophrenia (SZ) remains elusive, oxidative stress, inflammatory syndrome and immune activation have become an attractive hypothesis for explaining the pathophysiology of SZ. Data from prior studies on the role of matrix metalloproteinase 9 (MMP-9) and brain-derived neurotrophic factor (BDNF) single nucleotide polymorphisms (SNPs) in SZ are contradictory. We aimed to investigate whether oxidative stress, inflammatory and immune activation markers as well as MMP-9 levels may be implicated in SZ pathogenesis. The association of MMP-9 and BDNF SNPs with the clinical expression of SZ was examined.Ninety-four subjects were recruited, including 44 SZ patients and 50 healthy controls. Serum levels of thiobarbituric acid reactive substances (TBARS), protein carbonyl content (PCC), nitrite, C-reactive protein (CRP), interleukin 6 (IL-6), tumor necrosis factor alpha (TNF-α), Beta-2 microglobulin (Β2M), complement component 3 (C3), C4 and MMP-9 were measured. The MMP-9 − 1562C > T and BDNF196G > A SNPs were genotyped using polymerase chain reaction-restriction fragment length polymorphism assay. Psychopathology was assessed using the positive and negative syndrome scale (PANSS).SZ patients showed significantly higher TBARS, PCC, nitrite, CRP, IL-6, TNF-α, Β2M, C3 and MMP-9 levels than controls. In distinguishing SZ patients from healthy controls, CRP and MMP-9 yielded similar discriminatory performance, and both perform better than IL-6, Β2M, C3, nitrite, TBARS, PCC, TNF-α and C4. The MMP-9 − 1562C > T SNP genotypes distribution didn't differ significantly between controls and SZ patients. As compared to controls, SZ patients harbor a significantly higher frequency of the BDNF196GG genotype and a lower frequency of the BDNF196GA/AA genotype. Patients carrying the MMP-9 − 1562CC or BDNF196GG genotype revealed a significantly higher PANSS than those carrying MMP-9 − 1562CT/TT or BDNF196GA/AA genotype. Male gender and the MMP-9 − 1562CC genotype were identified as independent predictive factors for higher PANSS.Redox dysregulation and alterations in the immuno-inflammatory pathways are major culprits in the pathogenesis of SZ. MMP-9 and BDNF SNPs are associated with the clinical phenotype of SZ and, thus, may be a useful marker predicting the phenotypic expression and prognosis of SZ patients.

Associations Between Three Microrna Gene Polymorphisms and Schizophrenia Susceptibility in a Han Chinese Population.

The C(−1562)T Polymorphism of Matrix Metalloproteinase-9 Gene is Associated with Schizophrenia in China

Systematic association analysis of microRNA machinery genes with schizophrenia informs further study

Evaluation of Six SNPs of MicroRNA Machinery Genes and Risk of Schizophrenia

Association between two single nucleotide polymorphisms at corresponding microRNA and schizophrenia in a Chinese population

Identification of Mir-22-3p, Mir-92A-3p, and Mir-137 in Peripheral Blood As Biomarker for Schizophrenia.

Polymorphisms in Microrna Target Sites Influence Susceptibility to Schizophrenia by Altering the Binding of Mirnas to Their Targets

MicroRNAs and target site screening reveals a pre-microRNA-30e variant associated with schizophrenia

Diagnostic Value of Blood-Derived Micrornas for Schizophrenia: Results of a Meta-Analysis and Validation

Association of MicroRNA137 Gene Polymorphisms with Age at Onset and Positive Symptoms of Schizophrenia in a Han Chinese Population

Polymorphisms in MicroRNA Genes And Genes Involving in NMDAR Signaling and Schizophrenia: A Case-Control Study in Chinese Han Population

Converging evidence implicates the abnormal microRNA system in schizophrenia.

Sex-Specific Associations of MIR137 Polymorphisms With Schizophrenia in a Han Chinese Cohort

Gene Polymorphisms of Mir-323B and Mir-1343 That Regulate Kininogen L Are Associated with Schizophrenia Susceptibility: A Preliminary Population‑based Study

MicroRNA-137 Inhibits EFNB2 Expression Affected by a Genetic Variant and is Expressed Aberrantly in Peripheral Blood of Schizophrenia Patients

A role for miR-19 in the migration of adult-born neurons and schizophrenia

Genetic Association Analysis of Microrna137 and Its Target Complex 1 with Schizophrenia in Han Chinese.

Deregulatory miRNA-BDNF Network Inferred from Dynamic Expression Changes in Schizophrenia

MicroRNA Schizophrenia: Etiology, Biomarkers and Therapeutic Targets

The Relationship Between Gene Polymorphism of Mirnas Regulating FGA and Schizophrenia

A preliminary analysis of microRNA as potential clinical biomarker for schizophrenia